Cardiovascular outcomes trials have demonstrated reduced rates of major adverse cardiovascular events in high-risk patients treated with liraglutide (LEADER trial) and semaglutide (SUSTAIN-6 trial)
New approaches are offering hope where traditional methods max out
The overall direction of these changes moves gene expression patterns from states associated with disease and aging toward healthier profiles
The blood-brain barrier interface in diabetes mellitus: dysfunctions, mechanisms and approaches to treatment
Several widely used GLP-1 therapies, including Semaglutide and Tirzepatide, rely on pen injector systems to deliver medication accurately and safely
Years later, with additional clinical information available, Lutz came up with the suggestion that Beppu's group must have used serum/plasma from patients with one of the many autoimmune diseases that are characterized by anti-neutrophil cytoplasmic antibodies (ANCA) (Lutz, 2012)
